127 related articles for article (PubMed ID: 11559531)
1. Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.
Im YH; Kim HT; Kim IY; Factor VM; Hahm KB; Anzano M; Jang JJ; Flanders K; Haines DC; Thorgeirsson SS; Sizeland A; Kim SJ
Cancer Res; 2001 Sep; 61(18):6665-8. PubMed ID: 11559531
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
5. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.
Kanzler S; Meyer E; Lohse AW; Schirmacher P; Henninger J; Galle PR; Blessing M
Oncogene; 2001 Aug; 20(36):5015-24. PubMed ID: 11526486
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
8. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
Sanders S; Thorgeirsson SS
Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
Park DY; Hwang SY; Suh KS
Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells.
Engel JD; Kundu SD; Yang T; Lang S; Goodwin S; Janulis L; Cho JS; Chang J; Kim SJ; Lee C
Urology; 1999 Jul; 54(1):164-70. PubMed ID: 10414746
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
13. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
Jakowlew SB; Moody TW; You L; Mariano JM
Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
[TBL] [Abstract][Full Text] [Related]
14. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
Nishikawa Y; Wang M; Carr BI
J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
[TBL] [Abstract][Full Text] [Related]
16. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
18. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]